[Clinical unspecificity and metabolic specificity of the polarizing solution (author's transl)].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005947:Glucose / Q000627:therapeutic use*; D006003:Glycogen / Q000378:metabolism*; D006019:Glycolysis / Q000187:drug effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009132:Muscles / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D010429:Pentoses / Q000378:metabolism*; D011188:Potassium / Q000627:therapeutic use*
D007328:Insulin; D010429:Pentoses; D006003:Glycogen; D005947:Glucose; D011188:Potassium
La inespecificidad clínica y la especificidad metabólica de la solución polarizante